La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Cycad toxins and neurological diseases in guam : Defining theoretical and experimental standards for correlating human disease with environmental toxins

Identifieur interne : 000434 ( PascalFrancis/Curation ); précédent : 000433; suivant : 000435

Cycad toxins and neurological diseases in guam : Defining theoretical and experimental standards for correlating human disease with environmental toxins

Auteurs : Thomas E. Marler [États-Unis] ; Vivian Lee [Canada] ; Christopher A. Shaw [Canada]

Source :

RBID : Pascal:05-0424320

Descripteurs français

English descriptors

Abstract

Consumption of Cycas micronesica seed tissue has been associated with the amyotrophic lateral sclerosis-parkinsonism dementia complex (ALS-PDC) of the Western Pacific. However, failures to document vital plant and neighborhood descriptors and pronounced variability in toxin concentrations noted within and among studies obfuscate decades of research on this subject. We discuss the theoretical and experimental constraints of plant tissue sampling in relation to human disease research. Comparisons are made between this approach and methods used throughout the history of ALS-PDC research, most notably very recent reports concerning β-methyl-amino-alanine. Methods for studying possible plant neurotoxins need to be standardized and must follow rigorous criteria to be valid in principle. Our discussions reveal why these criteria are essential and highlight the impact that natural variations have on environmental toxin quantification and interpretation. Past research on cycad toxins is deficient on experimental and theoretical grounds, and interpretation of published data is dominated by ambiguities. This area of study as conventionally conceived and carried out needs transforming. We argue that future empirical studies should honor appropriate plant science standards concomitantly with medical science standards. This dual focus will ensure appropriate sampling scheme, sample size, and reporting of background plant and community factors known to influence phenotypic plasticity.
pA  
A01 01  1    @0 0018-5345
A02 01      @0 HJHSAR
A03   1    @0 HortScience
A05       @2 40
A06       @2 6
A08 01  1  ENG  @1 Cycad toxins and neurological diseases in guam : Defining theoretical and experimental standards for correlating human disease with environmental toxins
A11 01  1    @1 MARLER (Thomas E.)
A11 02  1    @1 LEE (Vivian)
A11 03  1    @1 SHAW (Christopher A.)
A14 01      @1 College of Natural and Applied Sciences, University of Guam, UOG Station @2 Mangilao, Guam 96923 @3 USA @Z 1 aut.
A14 02      @1 Department of Ophthalmology, University of British Columbia @2 Vancouver BC @3 CAN @Z 2 aut. @Z 3 aut.
A20       @1 1598-1606
A21       @1 2005
A23 01      @0 ENG
A43 01      @1 INIST @2 13300 @5 354000132128900010
A44       @0 0000 @1 © 2005 INIST-CNRS. All rights reserved.
A45       @0 1 p.1/4
A47 01  1    @0 05-0424320
A60       @1 P
A61       @0 A
A64 01  1    @0 HortScience
A66 01      @0 USA
C01 01    ENG  @0 Consumption of Cycas micronesica seed tissue has been associated with the amyotrophic lateral sclerosis-parkinsonism dementia complex (ALS-PDC) of the Western Pacific. However, failures to document vital plant and neighborhood descriptors and pronounced variability in toxin concentrations noted within and among studies obfuscate decades of research on this subject. We discuss the theoretical and experimental constraints of plant tissue sampling in relation to human disease research. Comparisons are made between this approach and methods used throughout the history of ALS-PDC research, most notably very recent reports concerning β-methyl-amino-alanine. Methods for studying possible plant neurotoxins need to be standardized and must follow rigorous criteria to be valid in principle. Our discussions reveal why these criteria are essential and highlight the impact that natural variations have on environmental toxin quantification and interpretation. Past research on cycad toxins is deficient on experimental and theoretical grounds, and interpretation of published data is dominated by ambiguities. This area of study as conventionally conceived and carried out needs transforming. We argue that future empirical studies should honor appropriate plant science standards concomitantly with medical science standards. This dual focus will ensure appropriate sampling scheme, sample size, and reporting of background plant and community factors known to influence phenotypic plasticity.
C02 01  X    @0 002A32
C02 02  X    @0 002B30A
C02 03  X    @0 002B03A
C02 04  X    @0 002B17G
C03 01  X  FRE  @0 Trouble neurologique @5 01
C03 01  X  ENG  @0 Neurological disorder @5 01
C03 01  X  SPA  @0 Trastorno neurológico @5 01
C03 02  X  FRE  @0 Etalon @5 02
C03 02  X  ENG  @0 Standard @5 02
C03 02  X  SPA  @0 Marco @5 02
C03 03  X  FRE  @0 Norme @5 03
C03 03  X  ENG  @0 Standards @5 03
C03 03  X  SPA  @0 Norma @5 03
C03 04  X  FRE  @0 Santé publique @5 04
C03 04  X  ENG  @0 Public health @5 04
C03 04  X  SPA  @0 Salud pública @5 04
C03 05  X  FRE  @0 Homme @5 05
C03 05  X  ENG  @0 Human @5 05
C03 05  X  SPA  @0 Hombre @5 05
C03 06  X  FRE  @0 Sclérose latérale amyotrophique @5 06
C03 06  X  ENG  @0 Amyotrophic lateral sclerosis @5 06
C03 06  X  SPA  @0 Esclerosis lateral amiotrófica @5 06
C03 07  X  FRE  @0 Parkinsonisme @2 NM @5 07
C03 07  X  ENG  @0 Parkinsonism @2 NM @5 07
C03 07  X  SPA  @0 Parkinson síndrome @2 NM @5 07
C03 08  X  FRE  @0 Parkinson démence ile de Guam @5 08
C03 08  X  ENG  @0 Guam Parkinson dementia @5 08
C03 08  X  SPA  @0 Demencia Guam Parkinson @5 08
C03 09  X  FRE  @0 Neurotoxine @5 09
C03 09  X  ENG  @0 Neurotoxin @5 09
C03 09  X  SPA  @0 Neurotoxina @5 09
C03 10  X  FRE  @0 Cycadales @2 NS @5 10
C03 10  X  ENG  @0 Cycadales @2 NS @5 10
C03 10  X  SPA  @0 Cycadales @2 NS @5 10
C03 11  X  FRE  @0 Espèce endémique @5 11
C03 11  X  ENG  @0 Endemic species @5 11
C03 11  X  SPA  @0 Especie endémica @5 11
C03 12  X  FRE  @0 Glucoside @5 16
C03 12  X  ENG  @0 Glucoside @5 16
C03 12  X  SPA  @0 Glucósido @5 16
C03 13  X  FRE  @0 Guam @2 NG @5 20
C03 13  X  ENG  @0 Guam @2 NG @5 20
C03 13  X  SPA  @0 Guam @2 NG @5 20
C03 14  X  FRE  @0 Constituant secondaire @5 28
C03 14  X  ENG  @0 Secondary constituent @5 28
C03 14  X  SPA  @0 Constituyente secundario @5 28
C03 15  X  FRE  @0 Stéroïde @5 29
C03 15  X  ENG  @0 Steroid @5 29
C03 15  X  SPA  @0 Esteroide @5 29
C03 16  X  FRE  @0 Horticulture @5 30
C03 16  X  ENG  @0 Horticulture @5 30
C03 16  X  SPA  @0 Horticultura @5 30
C03 17  X  FRE  @0 Cycas micronesica @4 INC @5 72
C03 18  X  FRE  @0 Alanine(3-méthylamino) @4 INC @5 78
C07 01  X  FRE  @0 Toxine
C07 01  X  ENG  @0 Toxin
C07 01  X  SPA  @0 Toxina
C07 02  X  FRE  @0 Gymnospermae @2 NS
C07 02  X  ENG  @0 Gymnospermae @2 NS
C07 02  X  SPA  @0 Gymnospermae @2 NS
C07 03  X  FRE  @0 Spermatophyta @2 NS
C07 03  X  ENG  @0 Spermatophyta @2 NS
C07 03  X  SPA  @0 Spermatophyta @2 NS
C07 04  X  FRE  @0 Mariannes @2 NG
C07 04  X  ENG  @0 Mariana Islands @2 NG
C07 04  X  SPA  @0 Marianas @2 NG
C07 05  X  FRE  @0 Micronésie @2 NG
C07 05  X  ENG  @0 Micronesia @2 NG
C07 05  X  SPA  @0 Micronesia @2 NG
C07 06  X  FRE  @0 Océanie @2 NG
C07 06  X  ENG  @0 Oceania @2 NG
C07 06  X  SPA  @0 Oceania @2 NG
C07 07  X  FRE  @0 Système nerveux pathologie @5 33
C07 07  X  ENG  @0 Nervous system diseases @5 33
C07 07  X  SPA  @0 Sistema nervioso patología @5 33
C07 08  X  FRE  @0 Maladie dégénérative @5 34
C07 08  X  ENG  @0 Degenerative disease @5 34
C07 08  X  SPA  @0 Enfermedad degenerativa @5 34
C07 09  X  FRE  @0 Moelle épinière pathologie @5 35
C07 09  X  ENG  @0 Spinal cord disease @5 35
C07 09  X  SPA  @0 Médula espinal patología @5 35
C07 10  X  FRE  @0 Extrapyramidal syndrome @5 36
C07 10  X  ENG  @0 Extrapyramidal syndrome @5 36
C07 10  X  SPA  @0 Extrapiramidal síndrome @5 36
C07 11  X  FRE  @0 Système nerveux central pathologie @5 37
C07 11  X  ENG  @0 Central nervous system disease @5 37
C07 11  X  SPA  @0 Sistema nervosio central patología @5 37
C07 12  X  FRE  @0 Encéphale pathologie @5 38
C07 12  X  ENG  @0 Cerebral disorder @5 38
C07 12  X  SPA  @0 Encéfalo patología @5 38
C07 13  X  FRE  @0 Aminoacide @5 50
C07 13  X  ENG  @0 Aminoacid @5 50
C07 13  X  SPA  @0 Aminoácido @5 50
N21       @1 297

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:05-0424320

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Cycad toxins and neurological diseases in guam : Defining theoretical and experimental standards for correlating human disease with environmental toxins</title>
<author>
<name sortKey="Marler, Thomas E" sort="Marler, Thomas E" uniqKey="Marler T" first="Thomas E." last="Marler">Thomas E. Marler</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>College of Natural and Applied Sciences, University of Guam, UOG Station</s1>
<s2>Mangilao, Guam 96923</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Lee, Vivian" sort="Lee, Vivian" uniqKey="Lee V" first="Vivian" last="Lee">Vivian Lee</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Ophthalmology, University of British Columbia</s1>
<s2>Vancouver BC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Shaw, Christopher A" sort="Shaw, Christopher A" uniqKey="Shaw C" first="Christopher A." last="Shaw">Christopher A. Shaw</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Ophthalmology, University of British Columbia</s1>
<s2>Vancouver BC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">05-0424320</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0424320 INIST</idno>
<idno type="RBID">Pascal:05-0424320</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000889</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000434</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Cycad toxins and neurological diseases in guam : Defining theoretical and experimental standards for correlating human disease with environmental toxins</title>
<author>
<name sortKey="Marler, Thomas E" sort="Marler, Thomas E" uniqKey="Marler T" first="Thomas E." last="Marler">Thomas E. Marler</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>College of Natural and Applied Sciences, University of Guam, UOG Station</s1>
<s2>Mangilao, Guam 96923</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Lee, Vivian" sort="Lee, Vivian" uniqKey="Lee V" first="Vivian" last="Lee">Vivian Lee</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Ophthalmology, University of British Columbia</s1>
<s2>Vancouver BC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Shaw, Christopher A" sort="Shaw, Christopher A" uniqKey="Shaw C" first="Christopher A." last="Shaw">Christopher A. Shaw</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Ophthalmology, University of British Columbia</s1>
<s2>Vancouver BC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">HortScience</title>
<title level="j" type="abbreviated">HortScience</title>
<idno type="ISSN">0018-5345</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">HortScience</title>
<title level="j" type="abbreviated">HortScience</title>
<idno type="ISSN">0018-5345</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amyotrophic lateral sclerosis</term>
<term>Cycadales</term>
<term>Endemic species</term>
<term>Glucoside</term>
<term>Guam</term>
<term>Guam Parkinson dementia</term>
<term>Horticulture</term>
<term>Human</term>
<term>Neurological disorder</term>
<term>Neurotoxin</term>
<term>Parkinsonism</term>
<term>Public health</term>
<term>Secondary constituent</term>
<term>Standard</term>
<term>Standards</term>
<term>Steroid</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Trouble neurologique</term>
<term>Etalon</term>
<term>Norme</term>
<term>Santé publique</term>
<term>Homme</term>
<term>Sclérose latérale amyotrophique</term>
<term>Parkinsonisme</term>
<term>Parkinson démence ile de Guam</term>
<term>Neurotoxine</term>
<term>Cycadales</term>
<term>Espèce endémique</term>
<term>Glucoside</term>
<term>Guam</term>
<term>Constituant secondaire</term>
<term>Stéroïde</term>
<term>Horticulture</term>
<term>Cycas micronesica</term>
<term>Alanine(3-méthylamino)</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Norme</term>
<term>Santé publique</term>
<term>Homme</term>
<term>Horticulture</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Consumption of Cycas micronesica seed tissue has been associated with the amyotrophic lateral sclerosis-parkinsonism dementia complex (ALS-PDC) of the Western Pacific. However, failures to document vital plant and neighborhood descriptors and pronounced variability in toxin concentrations noted within and among studies obfuscate decades of research on this subject. We discuss the theoretical and experimental constraints of plant tissue sampling in relation to human disease research. Comparisons are made between this approach and methods used throughout the history of ALS-PDC research, most notably very recent reports concerning β-methyl-amino-alanine. Methods for studying possible plant neurotoxins need to be standardized and must follow rigorous criteria to be valid in principle. Our discussions reveal why these criteria are essential and highlight the impact that natural variations have on environmental toxin quantification and interpretation. Past research on cycad toxins is deficient on experimental and theoretical grounds, and interpretation of published data is dominated by ambiguities. This area of study as conventionally conceived and carried out needs transforming. We argue that future empirical studies should honor appropriate plant science standards concomitantly with medical science standards. This dual focus will ensure appropriate sampling scheme, sample size, and reporting of background plant and community factors known to influence phenotypic plasticity.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0018-5345</s0>
</fA01>
<fA02 i1="01">
<s0>HJHSAR</s0>
</fA02>
<fA03 i2="1">
<s0>HortScience</s0>
</fA03>
<fA05>
<s2>40</s2>
</fA05>
<fA06>
<s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Cycad toxins and neurological diseases in guam : Defining theoretical and experimental standards for correlating human disease with environmental toxins</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>MARLER (Thomas E.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>LEE (Vivian)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>SHAW (Christopher A.)</s1>
</fA11>
<fA14 i1="01">
<s1>College of Natural and Applied Sciences, University of Guam, UOG Station</s1>
<s2>Mangilao, Guam 96923</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Department of Ophthalmology, University of British Columbia</s1>
<s2>Vancouver BC</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA20>
<s1>1598-1606</s1>
</fA20>
<fA21>
<s1>2005</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>13300</s2>
<s5>354000132128900010</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>1 p.1/4</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>05-0424320</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>HortScience</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Consumption of Cycas micronesica seed tissue has been associated with the amyotrophic lateral sclerosis-parkinsonism dementia complex (ALS-PDC) of the Western Pacific. However, failures to document vital plant and neighborhood descriptors and pronounced variability in toxin concentrations noted within and among studies obfuscate decades of research on this subject. We discuss the theoretical and experimental constraints of plant tissue sampling in relation to human disease research. Comparisons are made between this approach and methods used throughout the history of ALS-PDC research, most notably very recent reports concerning β-methyl-amino-alanine. Methods for studying possible plant neurotoxins need to be standardized and must follow rigorous criteria to be valid in principle. Our discussions reveal why these criteria are essential and highlight the impact that natural variations have on environmental toxin quantification and interpretation. Past research on cycad toxins is deficient on experimental and theoretical grounds, and interpretation of published data is dominated by ambiguities. This area of study as conventionally conceived and carried out needs transforming. We argue that future empirical studies should honor appropriate plant science standards concomitantly with medical science standards. This dual focus will ensure appropriate sampling scheme, sample size, and reporting of background plant and community factors known to influence phenotypic plasticity.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002A32</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B30A</s0>
</fC02>
<fC02 i1="03" i2="X">
<s0>002B03A</s0>
</fC02>
<fC02 i1="04" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Trouble neurologique</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Neurological disorder</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Trastorno neurológico</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Etalon</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Standard</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Marco</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Norme</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Standards</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Norma</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Santé publique</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Public health</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Salud pública</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Homme</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Human</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Sclérose latérale amyotrophique</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Amyotrophic lateral sclerosis</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Esclerosis lateral amiotrófica</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Parkinsonisme</s0>
<s2>NM</s2>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Parkinsonism</s0>
<s2>NM</s2>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Parkinson síndrome</s0>
<s2>NM</s2>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Parkinson démence ile de Guam</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Guam Parkinson dementia</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Demencia Guam Parkinson</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Neurotoxine</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Neurotoxin</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Neurotoxina</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Cycadales</s0>
<s2>NS</s2>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Cycadales</s0>
<s2>NS</s2>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Cycadales</s0>
<s2>NS</s2>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Espèce endémique</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Endemic species</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Especie endémica</s0>
<s5>11</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Glucoside</s0>
<s5>16</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>Glucoside</s0>
<s5>16</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Glucósido</s0>
<s5>16</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE">
<s0>Guam</s0>
<s2>NG</s2>
<s5>20</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG">
<s0>Guam</s0>
<s2>NG</s2>
<s5>20</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA">
<s0>Guam</s0>
<s2>NG</s2>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE">
<s0>Constituant secondaire</s0>
<s5>28</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG">
<s0>Secondary constituent</s0>
<s5>28</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA">
<s0>Constituyente secundario</s0>
<s5>28</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE">
<s0>Stéroïde</s0>
<s5>29</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG">
<s0>Steroid</s0>
<s5>29</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA">
<s0>Esteroide</s0>
<s5>29</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE">
<s0>Horticulture</s0>
<s5>30</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG">
<s0>Horticulture</s0>
<s5>30</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA">
<s0>Horticultura</s0>
<s5>30</s5>
</fC03>
<fC03 i1="17" i2="X" l="FRE">
<s0>Cycas micronesica</s0>
<s4>INC</s4>
<s5>72</s5>
</fC03>
<fC03 i1="18" i2="X" l="FRE">
<s0>Alanine(3-méthylamino)</s0>
<s4>INC</s4>
<s5>78</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Toxine</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Toxin</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Toxina</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Gymnospermae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Gymnospermae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Gymnospermae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Spermatophyta</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Spermatophyta</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Spermatophyta</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Mariannes</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Mariana Islands</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Marianas</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Micronésie</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Micronesia</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Micronesia</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Océanie</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Oceania</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Oceania</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>33</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>33</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>33</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>34</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>34</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>34</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE">
<s0>Moelle épinière pathologie</s0>
<s5>35</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG">
<s0>Spinal cord disease</s0>
<s5>35</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA">
<s0>Médula espinal patología</s0>
<s5>35</s5>
</fC07>
<fC07 i1="10" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>36</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>36</s5>
</fC07>
<fC07 i1="10" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>36</s5>
</fC07>
<fC07 i1="11" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="11" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="11" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="12" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="12" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>38</s5>
</fC07>
<fC07 i1="12" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="13" i2="X" l="FRE">
<s0>Aminoacide</s0>
<s5>50</s5>
</fC07>
<fC07 i1="13" i2="X" l="ENG">
<s0>Aminoacid</s0>
<s5>50</s5>
</fC07>
<fC07 i1="13" i2="X" l="SPA">
<s0>Aminoácido</s0>
<s5>50</s5>
</fC07>
<fN21>
<s1>297</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000434 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000434 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:05-0424320
   |texte=   Cycad toxins and neurological diseases in guam : Defining theoretical and experimental standards for correlating human disease with environmental toxins
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022